TP53 and hepatocellular carcinoma: Activation of P53 with Nutlin treatment in the HepG2 hepatoma cell line caused a decrease in NAA40 levels compared to DMSO treatment (0.7-fold difference between two groups, 2 samples per group), which could be reversed with treatment with shRNA against P53 but not control hairpin (GSE30137, Figure S6A).